Medtronic PLC (MDT)

Return on equity (ROE)

Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Apr 26, 2024 Jan 31, 2024 Jan 26, 2024 Oct 31, 2023 Oct 27, 2023 Jul 31, 2023 Jul 28, 2023 Apr 30, 2023 Apr 28, 2023 Jan 31, 2023 Jan 27, 2023 Oct 31, 2022 Oct 28, 2022 Jul 31, 2022 Jul 29, 2022
Net income (ttm) US$ in thousands 4,663,000 4,260,000 3,620,000 3,672,000 3,952,000 4,207,000 4,462,000 3,931,000 3,400,000 3,670,000 3,940,000 4,371,000 4,802,000 4,050,000 3,298,000 3,005,000 2,712,000 3,770,000 4,828,000 5,379,000
Total stockholders’ equity US$ in thousands 48,024,000 49,387,000 48,494,000 47,947,000 50,214,000 50,214,000 51,792,000 51,792,000 51,460,000 51,460,000 51,178,000 51,178,000 51,483,000 51,483,000 51,441,000 51,441,000 51,880,000 51,880,000 52,672,000 52,672,000
ROE 9.71% 8.63% 7.46% 7.66% 7.87% 8.38% 8.62% 7.59% 6.61% 7.13% 7.70% 8.54% 9.33% 7.87% 6.41% 5.84% 5.23% 7.27% 9.17% 10.21%

April 30, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,663,000K ÷ $48,024,000K
= 9.71%

The return on equity (ROE) for Medtronic PLC has exhibited some fluctuations over the reviewed periods. Starting at 10.21% in July 2022, the ROE showed a declining trend up to January 2023, reaching its lowest point of 5.23%. From there, the ROE gradually improved, with intermittent fluctuations, such as an increase in April 2023 to 9.33%. The ROE ranged between 6.41% to 8.62% from January 2023 to January 2024. The trend continued to fluctuate between 7.13% and 9.71% as of April 2025, indicating some volatility in Medtronic PLC's ability to generate profits from shareholders' equity. Overall, the ROE performance suggests that the company has been efficient in generating returns relative to its shareholders' investments, albeit with some variability in performance over the periods analyzed.


See also:

Medtronic PLC Return on Equity (ROE) (Quarterly Data)